Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-2.30%
$20.68
0% positive prob.
5-Day Prediction
-4.15%
$20.29
0% positive prob.
20-Day Prediction
-4.29%
$20.26
0% positive prob.
| Quarter | Signal | 1D Return | 5D Return | 20D Return | Confidence | Actual 5D |
|---|---|---|---|---|---|---|
| Q1 2026 | SELL | -2.30% | -4.15% | -4.29% | 100.0% | Pending |
| Q4 2025 | BUY | +8.82% | +9.98% | +13.09% | 100.0% | +0.86% |
SEC 8-K filings with transcript text
May 6, 2026 · 100% conf.
1D
-2.30%
$20.68
5D
-4.15%
$20.29
20D
-4.29%
$20.26
2 d302982dex991.htm
Exhibit 99.1
News Release
Contact:
Investors: Jeb Bachmann - Managing Director, Investor Relations - (615) 263-3024
Financial Media: David Gutierrez, Dresner Corporate Services - (312) 780-7204
BRENTWOOD, Tenn. – May 6, 2026 – CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its first quarter 2026 financial results.
Financial Highlights – First Quarter 2026
For the Three Months Ended March 31, 2026
% Increase from Prior Year Quarter
➣ Total revenue
$614.7 million
25.8%
➣ Net Income
$37.9 million
51.0%
➣ Diluted EPS
$0.38
65.2%
➣ Adjusted Diluted EPS
$0.40
73.9%
➣ Normalized FFO per diluted share
$0.65
44.4%
➣ Adjusted EBITDA
$110.1 million
36.0%
➣ Repurchased 2.3 million shares of our common stock at an aggregate cost of $44.7 million
Patrick Swindle, CoreCivic’s President and Chief Executive Officer, commented, “Our strong first quarter financial results were driven by the activation of four previously idled facilities since the first quarter of 2025. We anticipate increased demand from our federal, state, and local government partners in the second half of the year after a recent downturn due to enforcement redeployments and overall strategy adjustments within the Department of Homeland Security (DHS). We are well-positioned to meet demand given our readily available capacity, in both existing and idle facilities.”
“Consistent with CoreCivic’s strategy of allocating capital to high-return opportunities, subsequent to quarter-end we acquired Clinical Solutions Pharmacy (CSP), one of the largest providers of mail order pharmacy services to correctional facilities in the United States. This acquisition provides diversification of our cash flows in a complementary business and a growing market, and we are excited about the opportunities that lie ahead for CSP.”
Swindle continued, “Our balance sheet remains strong, supported by continued execution of our capital strategy. We ended the quarter with leverage, measured as net debt to Adjusted EBITDA, at 2.8x for the trailing twelve months. With the durability of our earnings and growth outlook, we were pleased to fortify our balance sheet with a $100 million incremental term loan subsequent to quarter-end. We obtained the incremental term loan to maintain our strong liquidity position, as we assess the debt capital markets and potential asset sales that could further enhance our liquidity, enabling us to continue to deploy capital in ways that we believe will create shareholder value.”
5501 Virginia Way, Brentwood, Tennessee 37027, Phone: 615-263-3000
First Quarter 2026 Financial Results
Page 2
First Quarter 2026 Financial Results Compared With First Quarter 2025
Net income in the first quarter of 2026 was $37.9 million, or $0.38 per diluted share, compared with net income in the first quarter of 2025 of $25.1 million, or $0.23 per diluted share (Diluted EPS). When adjusted for special items, which consisted of expenses associated with mergers and acquisitions and the associated income tax benefit in the first quarter of 2026, Adjusted Net Income was $39.7 million, or $0.40 per diluted share (Adjusted Diluted EPS). Expenses associated with mergers and acquisitions of $2.4 million during the first quarter of 2026 are included in general and administrative expenses. There were no special items during the first quarter of 2025. Special items are presented in detail in the calculation of Adjusted Net Income and Adjusted Diluted EPS in the Supplemental Financial Information following the financial statements presented herein.
The increase in Diluted EPS and Adjusted Diluted EPS compared with the prior year quarter resulted from the resumption of operations at the 2,400-bed Dilley Immigration Processing Center (Dilley Facility) in the first quarter of 2025, activations of previously idle facilities resulting from new contract awards at our 600-bed West Tennessee Detention Facility, our 2,560-bed California City Detention Facility, and our 2,160-bed Diamondback Correctional Facility, higher federal and state populations, and the acquisition of the Farmville Detention Center on July 1, 2025. Funding for the Dilley Facility was previously terminated effective August 9, 2024, and the facility remained idle until its reactivation effective March 5, 2025. Occupancy levels in our Safety and Community segments combined increased to 79.6% in the first quarter of 2026 compared with 77.0% in the first quarter of 2025.
Per share results were also favorably impacted by an increase of $4.6 million in employee retention credits (ERCs) available under the CARES Act during the first quarter of 2026 compared with the first quarter of 2025, and by a 10.1% decrease in weighted averag
Feb 11, 2026 · 100% conf.
1D
+8.82%
$20.13
Act: -3.46%
5D
+9.98%
$20.35
Act: +0.86%
20D
+13.09%
$20.92
8-K
false 0001070985 0001070985 2026-02-11 2026-02-11
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2026
CoreCivic, Inc. (Exact name of registrant as specified in its charter)
Maryland
001-16109
62-1763875
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
5501 Virginia Way Brentwood, Tennessee
37027
(Address of principal executive offices)
(Zip Code) (615) 263-3000 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
CXW
New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On February 11, 2026, CoreCivic, Inc., a Maryland corporation (the “Company”), issued a press release announcing its financial results for the quarter ended December 31, 2025 and introducing full-year guidance for 2026. A copy of the release is furnished as part of this Current Report as Exhibit 99.1 and incorporated herein by reference. The Company will hold a conference call to discuss its financial results for the quarter ended December 31, 2025 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time) on Thursday, February 12, 2026.
Item 9.01. Financial Statements and Exhibits.
(d) The following exhibits are filed as part of this Current Report:
99.1
Press Release dated February 11, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: February 11, 2026
By:
/s/ David M. Garfinkle
David M. Garfinkle Executive Vice President and Chief Financial Officer
Nov 5, 2025
8-K
false 0001070985 0001070985 2025-11-05 2025-11-05
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2025
CoreCivic, Inc. (Exact name of registrant as specified in its charter)
Maryland
001-16109
62-1763875
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
5501 Virginia Way Brentwood, Tennessee
37027
(Address of principal executive offices)
(Zip Code) (615) 263-3000 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
CXW
New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On November 5, 2025, CoreCivic, Inc., a Maryland corporation (the “Company”), issued a press release announcing its financial results for the quarter ended September 30, 2025 and updating full-year guidance for 2025. A copy of the release is furnished as part of this Current Report as Exhibit 99.1 and incorporated herein by reference. The Company will hold a conference call to discuss its financial results for the quarter ended September 30, 2025 at 1:30 p.m. Central Time (2:30 p.m. Eastern Time) on Thursday, November 6, 2025.
Item 9.01. Financial Statements and Exhibits.
(d) The following exhibits are filed as part of this Current Report:
99.1
Press Release dated November 5, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: November 5, 2025
By:
/s/ David M. Garfinkle
David M. Garfinkle Executive Vice President and Chief Financial Officer
This page provides CoreCivic Inc. (CXW) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on CXW's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.